The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4
Open accessAbstract
Low molecular weight fragmentation products of the polysaccharide of Hyaluronic acid (sHA) produced during inflammation have been shown to be potent activators of immunocompetent cells such as dendritic cells (DCs) and macrophages. Here we report that sHA induces maturation of DCs via the Toll-like receptor (TLR)-4, a receptor complex associated with innate immunity and host defense against bacterial infection. Bone marrow–derived DCs from C3H/HeJ and C57BL/10ScCr mice carrying mutant TLR-4 alleles were nonresponsive to sHA-induced phenotypic and functional maturation. Conversely, DCs from TLR-2–deficient mice were still susceptible to sHA. In accordance, addition of an anti–TLR-4 mAb to human monocyte–derived DCs blocked sHA-induced tumor necrosis factor α production. Western blot analysis revealed that sHA treatment resulted in distinct phosphorylation of p38/p42/44 MAP-kinases and nuclear translocation of nuclear factor (NF)-κB, all components of the TLR-4 signaling pathway. Blockade of this pathway by specific inhibitors completely abrogated the sHA-induced DC maturation. Finally, intravenous injection of sHA-induced DC emigration from the skin and their phenotypic and functional maturation in the spleen, again depending on the expression of TLR-4. In conclusion, this is the first report that polysaccharide degradation products of the extracellular matrix produced during inflammation might serve as an endogenous ligand for the TLR-4 complex on DCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ECM-bioscaffold degradation products function as damage-associated molecular patterns (DAMPs) that ligate pattern-recognition and scavenger receptors on dendritic cells and macrophages; in some contexts, they also signal via integrins [2,26,28,29].”
From Immune Response to Extracellular Matrix Bioscaffolds: A Comprehensive Review (2025) · cites this paper as [28]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
Self-citationTakeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80119-3 · Cited by 3,680
Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27489 · Cited by 3,374
Toll-like receptors in the induction of the innate immune response
Aderem, A. A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,082
MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4
Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., & Kimoto, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1777 · Cited by 2,187
Self-citationA family of human receptors structurally related to Drosophila Toll.
Rock, F., Hardiman, G., Timans, J., Kastelein, R., & Bazan, J. (1998) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.95.2.588 · Cited by 2,009
Laurent, T. C., & Fraser, J. R. E. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.7.1563592 · Cited by 2,004
MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways.
Medzhitov, R., Preston-Hurlburt, P., Kopp, E., Stadlen, A., Chen, C.-Q., Ghosh, S., & Janeway, C. (1998) · Molecules and Cells · doi:10.1016/s1097-2765(00)80136-7 · Cited by 1,783
Ohashi, K., Burkart, V., Flohé, S. B., & Kolb, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.558 · Cited by 1,607
Toll-like Receptor 2 Functions as a Pattern Recognition Receptor for Diverse Bacterial Products*
Lien, E., Sellati, T., Yoshimura, A., Flo, T., Rawadi, G., Finberg, R., Carroll, J. D., Espevik, T., Ingalls, R., Radolf, J., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33419 · Cited by 1,062
Flagged first, then by citations
Research works printed but not linked: 5
- 1998, Lab. Invest., 78, 987
- 2000, Chem. Immunol., 74, 61
- 1991, Cancer Res., 51, 2524
- 1999, Cancer Res., 59, 1287
- 1994, Cancer Res., 54, 2419
Cited by
Sorted by citations
Items 401–500 of 1,001
Proost, P., Verpoest, S., de Borne, K. V., Schutyser, E., Struyf, S., Put, W., Ronsse, I., Grillet, B. A. M., Opdenakker, G., & Damme, J. V. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1003524 · Cited by 93
Highly Efficient Syntheses of Hyaluronic Acid Oligosaccharides
Huang, L., & Huang, X. (2006) · Chemistry - A European Journal · doi:10.1002/chem.200601090 · Cited by 93
Contact dermatitis: from pathomechanisms to immunotoxicology
Martin, S. F. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01471.x · Cited by 97
Toll-like receptor activation: from renal inflammation to fibrosis
Yiu, W. H., Lin, M. Y., & Tang, S. C. W. (2014) · Kidney International Supplements · doi:10.1038/kisup.2014.5 · Cited by 93
Hyaluronan in immune dysregulation and autoimmune diseases
Nagy, N., Kuipers, H. F., Marshall, P. L., Wang, E., Kaber, G., & Bollyky, P. L. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.022 · Cited by 94
Li, X., Huang, L., Liu, G., et al. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112365 · Cited by 92
Toll-Like Receptor 4: A Novel Signaling Pathway During Renal Fibrogenesis
Campbell, M. T., Hile, K. L., Zhang, H., 浅沼, 宏., VanderBrink, B. A., Rink, R. C., & Meldrum, K. K. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2009.09.053 · Cited by 90
NF-κB Protects Macrophages from Lipopolysaccharide-induced Cell Death
Ma, Y., Temkin, V., Liu, H., & Pope, R. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510849200 · Cited by 93
NOX enzymes and Toll-like receptor signaling
Ogier‐Denis, É., Mkaddem, S. B., & Vandewalle, A. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0120-9 · Cited by 94
Primer: Toll-like receptor signaling pathways—what do rheumatologists need to know?
O'Neill, L. A. J. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0802 · Cited by 93
Evolutionary clues to the functions of the Toll-like family as surveillance receptors
Johnson, G. B. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)00014-5 · Cited by 92
Organ Preservation into the 2020s: The Era of Dynamic Intervention
Petrenko, O., Carnevale, M. E., Somov, A. Y., Osorio, J., Rodriguez, J. V., Guibert, E. E., Fuller, B. J., & Froghi, F. (2019) · Transfusion Medicine and Hemotherapy · doi:10.1159/000499610 · Cited by 92
Hyaluronic Acid: Known for Almost a Century, but Still in Vogue
Lierová, A., Kašparová, J., Filipová, A., Čížková, J., Pekarova, L., Korecká, L., Mannová, N., Bı́lková, Z., & Šinkorová, Z. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040838 · Cited by 100
The most promising microneedle device: present and future of hyaluronic acid microneedle patch
Kang, H., Zuo, Z., Lin, R., Yao, M., Han, Y., & Han, J. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2125600 · Cited by 96
Toll-like receptors and other links between innate and acquired alloimmunity
Goldstein, D. R. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.08.001 · Cited by 91
New findings in osteoarthritis pathogenesis: therapeutic implications
Pulsatelli, L., Addimanda, O., Brusi, V., Pavloska, B., & Melicòni, R. (2012) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622312462734 · Cited by 93
The Role of Hyaluronan and the Extracellular Matrix in Islet Inflammation and Immune Regulation
Bollyky, P. L., Bogdani, M., Bollyky, J., Hull, R. L., & Wight, T. N. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0297-0 · Cited by 94
Toll-like receptors in central nervous system injury and disease: A focus on the spinal cord
Heiman, A., Pallottie, A., Heary, R. F., & Elkabes, S. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.203 · Cited by 91
Donelan, W., Dominguez‐Gutierrez, P. R., & Kusmartsev, S. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.971278 · Cited by 90
Hill, D. R., Kessler, S. P., Rho, H. K., Cowman, M. K., & de la Motte, C. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.356238 · Cited by 92
Heat Shock Proteins in Immunity
Multhoff, G. (2005) · Springer eBooks · doi:10.1007/3-540-29717-0_12 · Cited by 90
A Clear and Present Danger: Endogenous Ligands of Toll-like Receptors
Sloane, J. A., Blitz, D., Margolin, Z. R., & Vartanian, T. K. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8094-x · Cited by 86
Martinvalet, D. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0237-7 · Cited by 94
Bioactivity in an Aggrecan 32‐mer Fragment Is Mediated via Toll‐like Receptor 2
Lees, S., Golub, S. B., Last, K., Zeng, W., Jackson, D. C., SUTTON, P. R. N., & Fosang, A. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39063 · Cited by 93
Role of toll-like receptors in tissue repair and tumorigenesis
Rakoff-Nahoum, S., & Medzhitov, R. M. (2008) · Biochemistry (Moscow) · doi:10.1134/s0006297908050088 · Cited by 91
Stenzel, W., Soltek, S., Sánchez-Ruiz, M., Akira, S., Miletic, H., Schlüter, D., & Deckert, M. (2008) · American Journal of Pathology · doi:10.2353/ajpath.2008.070567 · Cited by 96
Antmen, E., Vrana, N. E., & Hasırcı, V. (2021) · Biomaterials Science · doi:10.1039/d1bm00840d · Cited by 90
Pattern Recognition by Toll-like Receptors
Bauer, S., Müller, T. R., & Hamm, S. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-0901-5_2 · Cited by 88
From Secretome Analysis to Immunology
VILLIERS, C. L., Chevallet, M., Diemer, H., Couderc, R., Freitas, H., DORSSELAER, A. V., Marche, P. N., & Rabilloud, T. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800589-mcp200 · Cited by 88
Hyaluronan-Inorganic Nanohybrid Materials for Biomedical Applications
Cai, Z., Zhang, H., Wei, Y. Z., & Cong, F. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b00424 · Cited by 87
Asari, A., Kanemitsu, T., & Kurihara, H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.104950 · Cited by 86
Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report
Ichim, T. E., Solano, F., Lara, F., Paris, E., Ugalde, F., Rodriguez, J., Minev, B., Bogin, V., Ramos, F., Woods, E. J., et al. (2010) · International Archives of Medicine · doi:10.1186/1755-7682-3-30 · Cited by 87
Song, R., Zeng, Q., Ao, L., Yu, J. A., Cleveland, J. C., Zhao, K.-S., Fullerton, D. A., & Meng, X. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300116 · Cited by 86
Hyaluronan‐CD44/RHAMM interaction‐dependent cell proliferation and survival in lung cancer cells
Song, J. M., Im, J., Nho, R. S., Han, Y. H., Upadhyaya, P., & Kassie, F. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22930 · Cited by 88
Margina, D. M., Ungurianu, A., Purdel, C. N., Nițulescu, G. M., Tsoukalas, D., Sarandi, E., Thanasoula, M., Burykina, T. I., Tekos, F., Djordjević, A. B., et al. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111558 · Cited by 86
Innate immune sensing of cell death in disease and therapeutics
Man, S. M., & Kanneganti, T. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01491-y · Cited by 94
Regulation of remyelination in multiple sclerosis
Hanafy, K. A., & Sloane, J. A. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.048 · Cited by 89
Hyaluronan Receptors as Mediators and Modulators of the Tumor Microenvironment
Carvalho, A. M., Reis, R. L., & Pashkuleva, I. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202202118 · Cited by 87
Spirig, R., Djafarzadeh, S., Regueira, T., Shaw, S., von Garnier, C., Takala, J. A., Jakob, S. M., Rieben, R., & Lepper, P. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010983 · Cited by 88
Kindzelskii, A. L., Elner, V. M., Elner, S. G., Yang, D., Hughes, B. A., & Petty, H. R. (2004) · The Journal of General Physiology · doi:10.1085/jgp.200409062 · Cited by 86
Extracellular matrix molecules: endogenous danger signals as new drug targets in kidney diseases
Schaefer, L. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.11.007 · Cited by 84
Hyaluronan and Human Endothelial Cell Behavior
Genasetti, A., Vigetti, D., Viola, M., Karousou, E., Moretto, P., Rizzi, M., Bartolini, B., Clerici, M., Pallotti, F., Luca, G. D., et al. (2008) · Connective Tissue Research · doi:10.1080/03008200802148462 · Cited by 87
Hyaluronan digestion controls DC migration from the skin
Muto, J., Morioka, Y., Yamasaki, K., Kim, M., Garcia, A., Carlin, A. F., Varki, A., & Gallo, R. L. (2014) · Journal of Clinical Investigation · doi:10.1172/jci67947 · Cited by 84
Plant lectins are novel Toll-like receptor agonists
Unitt, J. F., & Hornigold, D. C. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.03.010 · Cited by 84
Chaaban, H., Keshari, R. S., Silasi‐Mansat, R., Popescu, N. I., Mehta-D’souza, P., Lim, Y., & Lupu, F. (2015) · Blood · doi:10.1182/blood-2014-06-582759 · Cited by 84
Ultaigh, S. N. A., Saber, T., McCormick, J., Connolly, M., Dellacasagrande, J., Keogh, B., McCormack, W. J., Reilly, M., O'Neill, L. A. J., McGuirk, P., et al. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3261 · Cited by 85
Agonists of Toll-like Receptors 2 and 4 Activate Airway Smooth Muscle via Mononuclear Leukocytes
Morris, G. E., Whyte, M. K. B., Martin, G. F., Jose, P. J., Dower, S., & Sabroe, I. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200403-406oc · Cited by 83
Harnessing Biomaterials to Engineer the Lymph Node Microenvironment for Immunity or Tolerance
Andorko, J. I., Hess, K. L., & Jewell, C. M. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9708-2 · Cited by 84
Variation in the toll-like receptor 4 gene and susceptibility to myocardial infarction
Holloway, J. W., Yang, I. A., & Ye, S. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01213011-200501000-00003 · Cited by 83
Impact of Toll-like receptor 4 polymorphisms on risk of cancer
Kutikhin, A. G. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.11.003 · Cited by 83
Therapeutic potential of the immunomodulatory activities of adult mesenchymal stem cells
Aronin, C. E. P., & Tuan, R. S. (2010) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.20174 · Cited by 83
HA metabolism in skin homeostasis and inflammatory disease
Kavasi, R., Berdiaki, A., Spyridaki, I., Corsini, E., Tsatsakis, A. M., Tzanakakis, G. N., & Nikitovic, D. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.01.012 · Cited by 88
Kato, J., & Svensson, C. I. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2014.11.014 · Cited by 85
Tumor-Associated Extracellular Matrix: How to Be a Potential Aide to Anti-tumor Immunotherapy?
He, Y., Liu, T., Dai, S., Xu, Z., Wang, L., & Luo, F. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.739161 · Cited by 85
High-yield novel leech hyaluronidase to expedite the preparation of specific hyaluronan oligomers
Jin, P. K., Kang, Z., Zhang, N., et al. (2014) · Scientific Reports · doi:10.1038/srep04471 · Cited by 82
Hyaluronan differently modulates TLR‐4 and the inflammatory response in mouse chondrocytes
Campo, G. M., Avenoso, A., D’Ascola, A., Prestipino, V., Scuruchi, M., Nastasi, G., Calatroni, A., & Campo, S. (2012) · BioFactors · doi:10.1002/biof.202 · Cited by 84
Toll-like receptor 4 modulates the cochlear immune response to acoustic injury
Vethanayagam, R. R., Yang, W., Dong, Y., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.156 · Cited by 82
Innate Immune Regulation by Toll-Like Receptors in the Brain
Mallard, C. E. (2012) · ISRN Neurology · doi:10.5402/2012/701950 · Cited by 82
Thomas, L. M., & Salter, R. D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001231 · Cited by 86
Haglund, L., Bernier, S. M., Önnerfjord, P., & Recklies, A. D. (2007) · Matrix Biology · doi:10.1016/j.matbio.2007.09.009 · Cited by 82
Tamm‐Horsfall protein: a multilayered defence molecule against urinary tract infection
Säemann, M. D., Weichhart, T., Hörl, W. H., & Zlabinger, G. J. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01483.x · Cited by 80
Activation of Dendritic Cells by Toll-Like Receptors and C-Type Lectins
Diebold, S. S. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-71029-5_1 · Cited by 84
Hyaluronan in intestinal homeostasis and inflammation: implications for fibrosis
de la Motte, C. A. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00063.2011 · Cited by 80
Matsuwaki, Y., Wada, K., White, T. A., Benson, L. M., Charlesworth, M. C., Checkel, J. L., Inoue, Y., Hotta, K., Ponikau, J. U., Lawrence, C. B., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901220 · Cited by 79
Automated Solid-Phase Synthesis of Hyaluronan Oligosaccharides
Walvoort, M. T. C., Volbeda, A. G., Reintjens, N. R. M., van den Elst, H., Plante, O. J., Overkleeft, H. S., van der Marel, G. A., & Codée, J. D. C. (2012) · Organic Letters · doi:10.1021/ol301666n · Cited by 79
Toll-Like Receptors and Myocardial Inflammation
Feng, Y., & Chao, W. (2011) · International Journal of Inflammation · doi:10.4061/2011/170352 · Cited by 83
Papakonstantinou, E., & Karakiulakis, G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00279.x · Cited by 75
Yoshida, M., Mata, J., & Babensee, J. E. (2006) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30832 · Cited by 78
Kropf, P., Freudenberg, N., Kalis, C., Modolell, M., Herath, S., Galanos, C., Freudenberg, M. A., & Müller, I. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1003484 · Cited by 78
Self-citationTLR Activation Induces TNF-α Production from Adult Neural Stem/Progenitor Cells
Covacu, R., Arvidsson, L., Andersson, Å., Khademi, M., Erlandsson-Harris, H., Harris, R. A., Svensson, M. A., Olsson, T. P., & Brundin, L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802907 · Cited by 78
In Silico and In Vivo Approach to Elucidate the Inflammatory Complexity of CD14-deficient Mice
Prince, J. M., Levy, R. M., Bartels, J. D., Baratt, A., Kane, J. M., Lagoa, C., Rubin, J. E., Day, J., Wei, J., Fink, M. P., et al. (2006) · Molecular Medicine · doi:10.2119/2006-00012.prince · Cited by 78
Min, H., Hong, J., Cho, I.-H., Jang, Y. H., Lee, H., Kim, D., Yu, S.-W., Lee, S., & Lee, S. J. (2015) · Molecular Brain · doi:10.1186/s13041-015-0116-z · Cited by 76
Role of TLR2‐dependent inflammation in metastatic progression
Kim, S.-H., & Karin, M. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05882.x · Cited by 78
Modulation of Inflammatory Responses by a Cannabinoid-2–Selective Agonist after Spinal Cord Injury
Adhikary, S., Li, H., Heller, J. E., Škarica, M., Zhang, M., Ganea, D., & Tuma, R. F. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2011.1853 · Cited by 77
Yasukawa, S., Miyazaki, Y., Yoshii, C., Nakaya, M., Ozaki, N., Toda, S., Kuroda, E., Ishibashi, K.-I., Yasuda, T., Natsuaki, Y., et al. (2014) · Nature Communications · doi:10.1038/ncomms4755 · Cited by 77
Land, W. G. (2011) · Transplantation Reviews · doi:10.1016/j.trre.2011.02.003 · Cited by 78
Li, Y., Xiang, M., Yuan, Y., Xiao, G., Zhang, J., Jiang, Y., Yoram Vodovotz, B., Billiar, T. R., Wilson, M. A., & Fan, J. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00445.2009 · Cited by 77
Pu, A., Stephenson, E. L., & Yong, V. W. (2018) · Glia · doi:10.1002/glia.23333 · Cited by 82
Prophylactic and therapeutic implications of toll-like receptor ligands
Hedayat, M., Takeda, K., & Rezaei, N. (2012) · Medicinal Research Reviews · doi:10.1002/med.20214 · Cited by 76
The anti-inflammatory activity of specific-sized hyaluronic acid oligosaccharides
Han, W., Lv, Y., Sun, Y., Wang, Y., Zhao, Z., Shi, C., Chen, X., Wang, L., Zhang, M., Wei, B., et al. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118699 · Cited by 79
Xiang, M., Fan, J., & Fan, J. (2010) · Mediators of Inflammation · doi:10.1155/2010/916425 · Cited by 79
Endogenous signals initiating inflammation in the injured nervous system
Pineau, I., & Lacroix, S. (2008) · Glia · doi:10.1002/glia.20763 · Cited by 78
Hernandez, M. L., Lay, J. C., Harris, B., Esther, C. R., Brickey, W. J., Bromberg, P. A., Díaz-Sánchez, D., Devlin, R. B., Kleeberger, S. R., Alexis, N. E., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.06.043 · Cited by 79
Kuang, D., Zhao, Q., Xu, J., Yun, J., Wu, C. Y., & Zheng, L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3089 · Cited by 76
Hyaluronic acid cues for functional endothelialization of vascular constructs
Ibrahim, S., & Ramamurthi, A. (2008) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.61 · Cited by 75
Humphries, J. E. (2003) · Integrative and Comparative Biology · doi:10.1093/icb/43.2.305 · Cited by 75
Hosono, K., Nishida, Y., Knudson, W., Knudson, C. B., Naruse, T., Suzuki, Y., & Ishiguro, N. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060828 · Cited by 75
Carbohydrate recognition systems in autoimmunity
Buzás, E. I., Buzás, E. I., György, B., Buzás, E. I., György, B., Pásztói, M., Jelinek, I., Falus, A., & Gabius, H. (2006) · Autoimmunity · doi:10.1080/08916930601061470 · Cited by 77
Role of immune reactions in drug-induced liver injury (DILI)
Ju, C., & Reilly, T. (2012) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.645579 · Cited by 73
IRAK1 deletion disrupts cardiac Toll/IL-1 signaling and protects against contractile dysfunction
Thomas, J. A., Haudek, S. B., Köroğlu, T., Tsen, M. F., Bryant, D. D., White, D. J., Kusewitt, D. F., Horton, J. W., & Giroir, B. P. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.0655.2001 · Cited by 74
Kuipers, H. F., Rieck, M., Gurevich, I., Nagy, N., Butte, M. J., Negrin, R. S., Wight, T. N., Steinman, L., & Bollyky, P. L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525086113 · Cited by 74
Matin, N., Tabatabaie, O., Falsaperla, R., Lubrano, R., Pavone, P., Mahmood, F., Gullotta, M., Serra, A., Mauro, P. D., Cocuzza, S. G., et al. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1034921 · Cited by 73
Toll-like receptors and chronic lung disease
Chaudhuri, N., Dower, S., Whyte, M. K. B., & Sabroe, I. (2005) · Clinical Science · doi:10.1042/cs20050044 · Cited by 75
Noninvasive Transdermal Vaccination Using Hyaluronan Nanocarriers and Laser Adjuvant
Kim, K. S., Kim, H., Park, Y., Kong, W. H., Lee, S. W., Kwok, S. J. J., Hahn, S. K., & Yun, S. H. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201504879 · Cited by 73
Toll-like receptor 4 deficiency: Smaller infarcts, but nogain in function
Kim, S.-C., Ghanem, A., Stapel, H., Tiemann, K., Knuefermann, P., Hoeft, A., Meyer, R., Grohé, C., Knowlton, A. A., & Baumgarten, G. (2007) · BMC Physiology · doi:10.1186/1472-6793-7-5 · Cited by 73
Ilievski, V., & Hirsch, E. (2010) · Biology of Reproduction · doi:10.1095/biolreprod.110.085464 · Cited by 72
Hyaluronan receptors involved in cytokine induction in monocytes
Yamawaki, H., Hirohata, S., Miyoshi, T., Takahashi, K., Ogawa, H., Shinohata, R., Demircan, K., Kusachi, S., Yamamoto, K., & Ninomiya, Y. (2008) · Glycobiology · doi:10.1093/glycob/cwn109 · Cited by 72
Innate Immune Recognition and Suppression of Tumors
Hayakawa, Y., & Smyth, M. J. (2006) · Advances in cancer research · doi:10.1016/s0065-230x(06)95008-8 · Cited by 71
Links between Toll-like receptor 4 and breast cancer
Ahmed, A., Redmond, H. P., & Wang, J. H. (2013) · OncoImmunology · doi:10.4161/onci.22945 · Cited by 74
A genetic basis for the “Adonis” phenotype of low adiposity and strong bones
Johnson, G. B., Riggs, B. L., & Platt, J. L. (2004) · The FASEB Journal · doi:10.1096/fj.04-1572fje · Cited by 71
Metadata
- Authors
- Termeer, C., Benedix, F., Sleeman, J., Fieber, C., Voith, U., Ahrens, T., Miyake, K., Freudenberg, M., Galanos, C., & Simon, J. C.
- Affiliations
- University of Freiburg (DE)
- 2Institute for Genetics, Forschungszentrum Karlsruhe, Karlsruhe D-76021, Germany
- University of Basel (CH)
- Institute of Medical Science, The University of Tokyo (JP)
- Max Planck Society (DE)
- 3Max-Planck Institute for Immunobiology, Freiburg D-79011, Germany
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2002-01-07
- Volume
- 195
- Issue
- 1
- Pages
- 99-111
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2196009
- OpenAlex
- W2126659405
- Semantic Scholar
- 44579905bd40557fb010b65248e3194bbd6a995d
- Cited by
- 1,378
- References
- 48
- Citations by year
- 2026: 19 · 2025: 29 · 2024: 28 · 2023: 28 · 2022: 32 · 2021: 54 · 2020: 46 · 2019: 40 · 2018: 40 · 2017: 41 · 2016: 54 · 2015: 59 · 2014: 71 · 2013: 61 · 2012: 69
- FWCI
- 18.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Max Planck Digital Library (submittedVersion)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- hyaluronic acid, oligosaccharides, dendritic cell maturation, TLR4, TLR2, innate immunity, endogenous ligands, MAPK signaling, TNF-α, extracellular matrix degradation, inflammation
- MeSH terms
- Animals, Cell Differentiation, Dendritic Cells, Female, Humans, Hyaluronic Acid, Membrane Glycoproteins, Mice, Inbred C3H, Mice, Inbred C57BL, Oligosaccharides, Receptors, Cell Surface, Tumor Necrosis Factor-alpha, Signal Transduction, Down-Regulation, NF-kappa B, Mitogen-Activated Protein Kinases, Drosophila Proteins, Toll-Like Receptors, Toll-Like Receptor 2, Toll-Like Receptor 4, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review